GlassScriptPhysician profile
Jack W Brand
NPI 1689678674
$3,422.65
in general payments reported to CMS, 2019-2025
26 companies · $92.41 in 2025
The $92.41 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2020: $380 · 2021: $722 · 2022: $278 · 2023: $448 · 2024: $531 · 2025: $92.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,164.61 | 2019-2025 | Jot Dx |
| E.R. Squibb & Sons, L.L.C. | $298.79 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $228.44 | 2019-2024 | Xarelto |
| Pfizer INC. | $200.04 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $187.91 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $156.02 | 2021-2025 | Verquvo |
| Amgen INC. | $121.09 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.04 | 2019-2024 | Lifevest |
| Amarin Pharma, INC. | $106.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.60 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $91.24 | 2019-2023 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $84.65 | 2019 | |
| Chiesi USA, INC. | $78.76 | 2019-2021 | |
| Nuwellis, INC. | $77.62 | 2024 | Aquadex Smartflow Console |
| Sanofi-Aventis U.S. LLC | $73.75 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $66.69 | 2019 | |
| Medtronic Vascular, INC. | $57.20 | 2019 | |
| Esperion Therapeutics, INC. | $37.49 | 2021-2022 | |
| Irhythm Technologies, INC. | $35.87 | 2024 | Zio Xt Patch, Zio Monitor |
| Bard Peripheral Vascular, INC. | $31.09 | 2022 | |
| Boston Scientific Corporation | $26.71 | 2022 | |
| Impulse Dynamics (USA) INC. | $26.71 | 2023 | Optimizer |
| Medtronic, INC. | $20.45 | 2024 | Linq II |
| Abiomed | $18.30 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2023 | |
| Medicomp INC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Brand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.